238 related articles for article (PubMed ID: 30357882)
1. Durable left ventricular assist device implantation in extremely obese heart failure patients.
Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
[TBL] [Abstract][Full Text] [Related]
2. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
Mohamedali B; Yost G; Bhat G
J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
[TBL] [Abstract][Full Text] [Related]
3. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
[TBL] [Abstract][Full Text] [Related]
4. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices.
Volkovicher N; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Manon M; Civitello AB; Morgan JA
J Artif Organs; 2018 Jun; 21(2):180-187. PubMed ID: 29372417
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of obese patients undergoing less invasive LVAD implantation.
Voorhees HJ; Sorensen EN; Pasrija C; Kaczorowski D; Griffith BP; Kon ZN
J Card Surg; 2019 Dec; 34(12):1465-1469. PubMed ID: 31692120
[TBL] [Abstract][Full Text] [Related]
6. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation.
Brewer RJ; Lanfear DE; Sai-Sudhakar CB; Sundareswaran KS; Ravi Y; Farrar DJ; Slaughter MS
J Heart Lung Transplant; 2012 Feb; 31(2):167-72. PubMed ID: 22305378
[TBL] [Abstract][Full Text] [Related]
7. Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart Failure.
Jeng EI; Miller AH; Friedman J; Tapia-Ruano SA; Reilly K; Parker A; Vilaro J; Aranda JM; Klodell CT; Beaver TM; Arnaoutakis GJ; Ahmed M
ASAIO J; 2021 Feb; 67(2):163-168. PubMed ID: 32701629
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results.
Chaudhry UI; Kanji A; Sai-Sudhakar CB; Higgins RS; Needleman BJ
Surg Obes Relat Dis; 2015; 11(1):88-93. PubMed ID: 25127439
[TBL] [Abstract][Full Text] [Related]
9. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of hemodynamic assessment during left ventricular assist device therapy.
Imamura T; Chung B; Nguyen A; Sayer G; Uriel N
J Cardiol; 2018 Apr; 71(4):352-358. PubMed ID: 29287808
[TBL] [Abstract][Full Text] [Related]
12. Destination therapy: one-year outcomes in patients with a body mass index greater than 30.
Coyle LA; Ising MS; Gallagher C; Bhat G; Kurien S; Sobieski MA; Slaughter MS
Artif Organs; 2010 Feb; 34(2):93-7. PubMed ID: 19995363
[TBL] [Abstract][Full Text] [Related]
13. Effect of Body Mass Index on Outcomes in Left Ventricular Assist Device Recipients.
Go PH; Nemeh HW; Borgi J; Paone G; Morgan JA
J Card Surg; 2016 Apr; 31(4):242-7. PubMed ID: 26856974
[TBL] [Abstract][Full Text] [Related]
14. Study results suggest less invasive HeartMate 3 implantation is a safe and effective approach for obese patients.
Bjelic M; Ayers B; Paic F; Bernstein W; Barrus B; Chase K; Gu Y; Alexis JD; Vidula H; Cheyne C; Prasad S; Gosev I
J Heart Lung Transplant; 2021 Sep; 40(9):990-997. PubMed ID: 34229916
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
[TBL] [Abstract][Full Text] [Related]
16. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and outcome after ventricular assist device placement.
Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
[TBL] [Abstract][Full Text] [Related]
18. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
[TBL] [Abstract][Full Text] [Related]
19. Impact of Change in Body Mass Index on Outcomes After Left Ventricular Assist Device Implantation in Obese Patients.
Mano A; Kilic A; Lampert BC; Smith SA; Whitson B; Hasan AK
ASAIO J; 2019; 65(7):668-673. PubMed ID: 30198911
[TBL] [Abstract][Full Text] [Related]
20. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
